Abeona Therapeutics Inc (ABEO)

Apr 02, 2025

Breakeven On The Horizon For Abeona Therapeutics Inc. (NASDAQ:ABEO) - simplywall.st

Apr 02, 2025

Apr 01, 2025

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times

Apr 01, 2025

Apr 01, 2025

Abeona Therapeutics Expands Team with Strategic Stock Grants for Key New Talent - Stock Titan

Apr 01, 2025

Mar 31, 2025

Abeona Therapeutics CEO sells shares worth $119,500 - Investing.com India

Mar 31, 2025

Mar 31, 2025

Abeona Therapeutics CEO sells shares worth $119,500 By Investing.com - Investing.com Australia

Mar 31, 2025

Mar 28, 2025

Abeona Therapeutics (NASDAQ:ABEO) Upgraded by StockNews.com to Hold Rating - MarketBeat

Mar 28, 2025

Mar 28, 2025

What is Zacks Small Cap’s Estimate for ABEO Q3 Earnings? - Defense World

Mar 28, 2025

Mar 27, 2025

What is Zacks Small Cap’s Forecast for ABEO Q1 Earnings? - Defense World

Mar 27, 2025

Mar 27, 2025

Equities Analysts Set Expectations for ABEO Q1 Earnings - Defense World

Mar 27, 2025

Mar 26, 2025

Trend Tracker for (ABEO) - news.stocktradersdaily.com

Mar 26, 2025

Mar 26, 2025

What is HC Wainwright’s Forecast for ABEO Q1 Earnings? - Defense World

Mar 26, 2025

Mar 25, 2025

Abeona Therapeutics (NASDAQ:ABEO) Given Buy Rating at HC Wainwright - Defense World

Mar 25, 2025

Mar 25, 2025

Abeona Therapeutics (NASDAQ:ABEO) Upgraded to Hold at StockNews.com - Defense World

Mar 25, 2025

Mar 24, 2025

Abeona Therapeutics: Positive Outlook Amid FDA Hopes - MSN

Mar 24, 2025

Mar 22, 2025

Abeona Therapeutics Inc. (NASDAQ:ABEO) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 22, 2025

Mar 21, 2025

Abeona planning potential US launch of pz-cel to treat RDEB - Epidermolysis Bullosa News

Mar 21, 2025

Mar 21, 2025

Abeona Therapeutics Inc (ABEO) Q4 2024 Earnings Call Highlights: Strategic Advancements and ... - Yahoo Finance

Mar 21, 2025

Mar 21, 2025

Abeona Therapeutics Inc (ABEO) Q4 2024 Earnings Call Highlights: Strategic Advancements and ... By GuruFocus - Investing.com Canada

Mar 21, 2025

Mar 21, 2025

Abeona Therapeutics Reports 2024 Financial Results - TipRanks

Mar 21, 2025

Mar 20, 2025

Earnings call transcript: Abeona Therapeutics reports Q4 2024 EPS beat - Investing.com India

Mar 20, 2025

Mar 20, 2025

Earnings call transcript: Abeona Therapeutics reports Q4 2024 EPS beat By Investing.com - Investing.com UK

Mar 20, 2025

Mar 20, 2025

Abeona Therapeutics targets $2B revenue potential for pz-cel amid U.S. launch preparations - MSN

Mar 20, 2025

Mar 20, 2025

Oppenheimer maintains Abeona Therapeutics Outperform rating - Investing.com India

Mar 20, 2025

Mar 20, 2025

Abeona Therapeutics® Reports Full Year 2024 Financial - GlobeNewswire

Mar 20, 2025

Mar 20, 2025

Abeona Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 20, 2025

Mar 20, 2025

ABEONA THERAPEUTICS INC. SEC 10-K Report - TradingView

Mar 20, 2025

Mar 20, 2025

Abeona Therapeutics® Reports Full Year 2024 Financial Results, Provides Pz-cel Regulatory - Bluefield Daily Telegraph

Mar 20, 2025

Mar 20, 2025

Abeona Strengthens to $98M Cash Position as FDA Decision for Pz-cel Approaches - StockTitan

Mar 20, 2025

Mar 16, 2025

(ABEO) On The My Stocks Page - news.stocktradersdaily.com

Mar 16, 2025

Mar 14, 2025

Abeona Therapeutics Inc expected to post a loss of 35 cents a shareEarnings Preview - TradingView

Mar 14, 2025

Mar 10, 2025

Abeona Therapeutics at Leerink’s Global Healthcare Conference: Launch Plans for PZcell - Investing.com Canada

Mar 10, 2025

Mar 10, 2025

Abeona Therapeutics (ABEO) Projected to Post Earnings on Monday - Defense World

Mar 10, 2025

Mar 07, 2025

Abeona Therapeutics (NASDAQ:ABEO) Coverage Initiated at Oppenheimer - Defense World

Mar 07, 2025

Mar 06, 2025

Oppenheimer Initiates Coverage of Abeona Therapeutics (ABEO) with Outperform Recommendation - MSN

Mar 06, 2025

Mar 05, 2025

This Krystal Biotech Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga

Mar 05, 2025

Mar 05, 2025

Oppenheimer Initiates Coverage of Abeona Therapeutics (LSE:0H7R) with Outperform Recommendation - Nasdaq

Mar 05, 2025

Mar 05, 2025

Trading (ABEO) With Integrated Risk Controls - Stock Traders Daily

Mar 05, 2025

Mar 05, 2025

Oppenheimer sets Abeona stock Outperform with $16 target By Investing.com - Investing.com Canada

Mar 05, 2025

Mar 04, 2025

Abeona Therapeutics® to Present at the Leerink Partners Global Healthcare Conference - GlobeNewswire

Mar 04, 2025

Mar 04, 2025

When Abeona Therapeutics Takes the Stage: CEO's Upcoming Leerink Conference Presentation - StockTitan

Mar 04, 2025

Mar 04, 2025

Abeona Therapeutics announces new employee inducement grants - Yahoo Finance

Mar 04, 2025

Mar 03, 2025

Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Marketscreener.com

Mar 03, 2025

Mar 03, 2025

How Abeona Therapeutics Is Structuring Compensation to Attract New Talent - StockTitan

Mar 03, 2025

Feb 27, 2025

Abeona Therapeutics Insider Stock Sales Prove Timely As Market Valuation Descends To US$232m - Simply Wall St

Feb 27, 2025

Feb 25, 2025

StockNews.com Downgrades Abeona Therapeutics (NASDAQ:ABEO) to Sell - MarketBeat

Feb 25, 2025

Feb 22, 2025

How the (ABEO) price action is used to our Advantage - Stock Traders Daily

Feb 22, 2025

Feb 21, 2025

Cell and Gene Therapies in Rare Disorders Market to Skyrocket Across the 7MM During the Forecast Period (2025–2034) | DelveInsight - GlobeNewswire Inc.

Feb 21, 2025

Feb 21, 2025

Abeona Therapeutics Inc (NASDAQ:ABEO) Short Interest Down 6.8% in January - MarketBeat

Feb 21, 2025

Feb 20, 2025

HC Wainwright Reaffirms "Buy" Rating for Abeona Therapeutics (NASDAQ:ABEO) - MarketBeat

Feb 20, 2025

Feb 20, 2025

Abeona Therapeutics’ (ABEO) Buy Rating Reaffirmed at HC Wainwright - Defense World

Feb 20, 2025

Feb 18, 2025

Epidermolysis Bullosa Market Expected to rise, 2034 | Amryt - openPR

Feb 18, 2025

Feb 17, 2025

Abeona Therapeutics Inc (NASDAQ:ABEO) Short Interest Update - Defense World

Feb 17, 2025